Business
uniQure to Participate in Multiple Upcoming Industry Conferences in June
~ uniQure to host virtual Research & Development Day on June 22, 2021 ~ LEXINGTON, Mass. and AMSTERDAM, June 02, 2021 (GLOBE NEWSWIRE) -- uniQure N.V.
About this update from Uniqure N.v.
[{"type":"text","content":"~ uniQure to host virtual Research & Development Day on June 22, 2021 ~\nLEXINGTON, Mass. and AMSTERDAM, June 02, 2021 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced its participation in the following upcoming virtual investor and scientific conferences: Jefferies Virtual Healthcare Conference, June 1 - 4, 2021 Members of uniQure’s management team will participate in virtual one-on-one investor meetings throughout the day on Wednesday, June 2.A fireside chat with Matt Kapusta, chief executive officer, will take place the same day from 8:30 to 8:55 a.m. ET. The live webcast of the fireside chat can be accessed through the link displayed in the Investors & Newsroom section of the uniQure website. European Hematology Association (EHA) Virtual 2021, June 7 - 13, 2021 uniQure will present two encore presentations respectively highlighting 26-week clinical data from the pivotal Phase 3 HOPE-B trial of the gene therapy etranacogene dezaparvovec in patients with severe to moderately severe hemophilia B. An oral presentation entitled “26 Week Efficacy and Safety of Etranacogene Dezaparvovec (AAV5-Padua HFIX Variant; AMT-130) in Adults with Severe or Moderate-Severe Hemophilia B Treated in the Phase 3 HOPE-B Clinical Trial” will be available on June 11, 2021 at 9:00 a.m. ET. A poster presentation entitled “Clinical Outcomes in Patients With and Without Pre-existing Neutralizing Antibodies to the Vector: 6-Month Data from the Phase 3 HOPE-B Gene Therapy Trial of Etranacogene Dezaparvovec” will be available on June 11, 2021 at 9:00 a.m. ET Goldman Sachs 42nd Annual Global Healthcare Conference, June 8 - 11, 2021 Members of uniQure’s management team will participate in virtual one-on-one investor meetings throughout the day on Wednesday, June 2.Matt Kapusta will participate in a fireside chat the same day at 4:40 to 5:20 p.m. ET. The live webcast of the fireside chat can be accessed through the link displayed in the Investors & Newsroom section of the uniQure website. uniQure’s Virtual Research & Development Day, June 22, 2021 uniQure will host a virtual Research & Development Day on June 22, 2021 at 8:30 to 11:30 a.m. ET to highlight new investments in its expanding gene therapy pipeline focusing on CNS and rare, liver...